Physician

Robert Marshall Rogers, M.D.

According to 2025 Medicare claims, Robert Rogers, M.D. (NPI: 1215989587) practices dermatology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is ROGERS DERMATOLOGY, P.A. (NPI: 1598923807; TIN: 26-0806225) and primary practice location at 29605-4019.

Rogers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,928 traditional Medicare patients, billed 20,174 HCPCS/CPT codes, and received $994,023 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 8,726 prescription claims across 2,533 beneficiaries totaling $1,562,469 in drug costs, led by Skyrizi (Risankizumab-Rzaa). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,121,767 to $1,562,469. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$511K$1.0M2015 Medicare payment: $942,989 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $946,362 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $882,041 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $988,510 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,014,455 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $897,612 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,012,902 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $994,690 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,021,933 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $994,023 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,91222,511$942,989
20163,01124,213$946,362
20172,80121,823$882,041
20182,86721,825$988,510
20192,94421,870$1,014,455
20202,60517,693$897,612
20212,89818,561$1,012,902
20222,89819,299$994,690
20233,06020,517$1,021,933
20242,92820,174$994,023

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$781K$1.6M2015 Drug cost: $1,121,767 (USD; Tot_Drug_Cst)2016 Drug cost: $754,777 (USD; Tot_Drug_Cst)2017 Drug cost: $936,560 (USD; Tot_Drug_Cst)2018 Drug cost: $861,245 (USD; Tot_Drug_Cst)2019 Drug cost: $943,138 (USD; Tot_Drug_Cst)2020 Drug cost: $890,079 (USD; Tot_Drug_Cst)2021 Drug cost: $897,707 (USD; Tot_Drug_Cst)2022 Drug cost: $1,235,023 (USD; Tot_Drug_Cst)2023 Drug cost: $1,367,625 (USD; Tot_Drug_Cst)2024 Drug cost: $1,562,469 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152,0216,880$1,121,767
20162,0476,968$754,777
20172,0856,582$936,560
20182,1276,741$861,245
20192,2506,832$943,138
20202,0426,138$890,079
20212,2746,934$897,707
20222,2366,737$1,235,023
20232,4278,182$1,367,625
20242,5338,726$1,562,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths523597$76
11102Biopsy of related skin growth, first growth632712$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2,4033,633$58
17000Destruction of precancer skin growth, 1 growth1,2441,649$38
17003Destruction of precancer skin growth, 2-14 growths9515,877$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SkyriziRisankizumab-Rzaa201,680$422,197
Humira(Cf) PenAdalimumab22644$200,643
TremfyaGuselkumab14756$186,257
EnbrelEtanercept25700$183,521
OtezlaApremilast27810$131,151

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Robert Marshall Rogers, M.D.?

Tedicare shows public-source Medicare data for Robert Marshall Rogers, M.D. (NPI 1215989587), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Marshall Rogers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Marshall Rogers, M.D.?

Robert Marshall Rogers, M.D. is linked to ROGERS DERMATOLOGY, P.A. (billing NPI 1598923807) in the available physician profile data.

Does Robert Marshall Rogers, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.